Cancer
Conditions
Interventions
control group:Treatment of oral Mecobalamin tablets
Treatment group:Electroacupuncture Treatment
Sponsors
Zhejiang Cancer Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: ? According to the diagnostic criteria of CIPN, recent use of utidelon chemotherapy resulted in grade I and above peripheral neuropathy; ? Age 18-70 years old; ? Have the ability of daily living, Karnofsky function score > 70, and can cooperate independently to complete all treatments; ? No severe diseases such as gravity center, liver, brain and kidney, and no serious mental diseases; ? Voluntarily participate and sign informed consent.
Exclusion criteria
Exclusion criteria: ? Those who do not meet the above requirements; ? Pregnant women, or combined with other serious diseases, end-stage cachexia, etc; ? Peripheral neuropathy caused by other diseases; ? Those who do not cooperate with the treatment or are participating in other acupuncture or drug clinical trials; ? Those who do not agree to participate in the clinical trial or cannot follow up on time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Peripheral neurotoxicity was assessed according to NCI CTCAE version 5.0;PNQ;EORTC QLQ-CIPN20; | — |
Secondary
| Measure | Time frame |
|---|---|
| EORTC QLQ-C30; | — |
Countries
China
Contacts
Public ContactLu Chao
Department of the Traditional Chinese Medicine ,Zhejiang Cancer Hospital
Outcome results
None listed